港股创新药短线突围，520880逆市收涨！后市怎么走？高盛：关注美联储12月降息概率

Core Viewpoint - The Hong Kong stock market continues to adjust, with the Hang Seng Index showing mixed performance, while the innovative drug sector demonstrates resilience, as evidenced by the performance of the Hong Kong Stock Connect Innovative Drug ETF (520880) which ended a four-day decline [1][3]. Group 1: Market Performance - The Hong Kong Stock Connect Innovative Drug ETF (520880) saw a price increase of 1.79% during the day, successfully ending its previous four-day decline [1]. - The ETF's performance is supported by major leading stocks in the innovative drug sector, with notable gains from companies such as Innovent Biologics, which rose by 2.84%, and others like China Biologic Products and Kintor Pharmaceutical, which increased by over 1% [1]. Group 2: Investment Insights - Following a strong rebound of nearly 7% the previous week, the ETF has returned to a state of fluctuation, currently trading at a near four-month low, indicating a potential area for cost-effective investment [3]. - The fund manager, Feng Chen, suggests that each significant pullback in the innovative drug sector presents an opportunity for accumulation [3]. - The innovative drug sector is undergoing a notable correction since early September, attributed to market style shifts and the return to more realistic expectations regarding business development (BD) rhythms and amounts [3]. Group 3: ETF Characteristics - The Hong Kong Stock Connect Innovative Drug ETF (520880) is characterized by three unique advantages: it is purely focused on innovative drug companies, has a significant concentration of leading stocks with over 71% weight in the top ten holdings, and maintains better risk control by reducing the weight of less liquid component stocks [3][4]. - The top ten holdings in the ETF account for 71.51% of the total weight, showcasing the dominance of leading companies in the sector [4]. - As of November 19, the ETF has a scale of 2.12 billion HKD and an average daily trading volume of 464 million HKD since its inception, making it the largest and most liquid ETF tracking the same index [4].